Home › Cardiotoxicity › Texas
Cardiotoxicity clinical trials in Texas
3 studies for Cardiotoxicity are looking for participants at sites in Texas.
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
- Texas Tech University Health Sciences Center, Lubbock
RecruitingPhase 1/2
Ages 18 to 89 · All sexes · Updated Jun 29, 2026 · NCT03934905AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Texas Cardiac Arrhythmia Research Foundation, Austin
- South Heart Clinic, Weslaco
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- UT Southwestern Clinical Center at Richardson/Plano, Richardson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2025 · NCT03418961From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.